Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18674694 | Urinary Drainage System with Air Pressure Apparatus | May 2024 | June 2025 | Allow | 13 | 1 | 0 | No | No |
| 18641163 | SYSTEMS AND METHODS FOR EXTENDING OPERATIONAL TIME OF NEGATIVE PRESSURE WOUND TREATMENT APPARATUSES | April 2024 | May 2025 | Allow | 13 | 0 | 0 | Yes | No |
| 18477633 | VARIABLE PARTICLE SIZE TISSUE COLLECTOR | December 2023 | June 2025 | Allow | 21 | 3 | 0 | No | No |
| 18190902 | CATHETER SYSTEMS AND METHODS FOR MEDICAL PROCEDURES USING CATHETERS | March 2023 | February 2026 | Allow | 35 | 1 | 1 | No | No |
| 17998981 | A MOBILE NEGATIVE PRESSURE WOUND THERAPY DEVICE | November 2022 | February 2025 | Allow | 27 | 4 | 0 | Yes | No |
| 17919316 | MULTI-VIAL CONNECTOR | October 2022 | December 2025 | Abandon | 38 | 1 | 0 | No | No |
| 17889423 | Devices for shunting blood | August 2022 | February 2026 | Allow | 42 | 3 | 1 | Yes | No |
| 17867918 | Female Urine Specimen Kit | July 2022 | February 2025 | Abandon | 31 | 3 | 0 | No | No |
| 17792065 | SYSTEMS AND METHODS FOR MONITORING OPERATIONAL LIFETIME OF NEGATIVE PRESSURE WOUND TREATMENT APPARATUSES | July 2022 | January 2026 | Allow | 42 | 3 | 0 | Yes | No |
| 17791329 | SYSTEMS AND METHODS FOR CONTROLLING FLUID INSTILLATION THERAPY USING PH FEEDBACK | July 2022 | September 2025 | Allow | 39 | 2 | 0 | No | No |
| 17748350 | KIDNEY STONE SUCTION TUBE DEVICE AND RELATED METHODS OF USE | May 2022 | June 2025 | Allow | 37 | 2 | 0 | Yes | No |
| 17745258 | BLOOD ANALYSIS SYSTEM | May 2022 | June 2025 | Abandon | 37 | 1 | 0 | No | No |
| 17730590 | Snag Resistant Blood Absorbence Pad And Method For Use By A Patient Having Braces | April 2022 | July 2024 | Abandon | 27 | 4 | 0 | No | No |
| 17657992 | METHODS OF TREATING A VESSEL USING AN ASPIRATION PATTERN | April 2022 | October 2025 | Allow | 42 | 1 | 0 | Yes | No |
| 17700328 | Absorbent Hygienic Article Having an Integrated Drainage Mechanism | March 2022 | October 2023 | Abandon | 19 | 1 | 0 | No | No |
| 17679283 | OXYGENATOR WITH PRESSURE RELIEF AND SAMPLING | February 2022 | February 2025 | Allow | 36 | 1 | 0 | No | No |
| 17645821 | MALE EXTERNAL CATHETER WITH ATTACHMENT INTERFACE CONFIGURED TO BIAS AGAINST PENIS | December 2021 | November 2025 | Allow | 47 | 4 | 1 | Yes | No |
| 17561504 | Urinary Drainage System with Air Pressure Apparatus | December 2021 | January 2024 | Allow | 25 | 3 | 0 | No | Yes |
| 17559096 | HAND CONTAMINATION PREVENTING DRAINAGE BAG STRUCTURE | December 2021 | October 2023 | Abandon | 22 | 1 | 0 | No | No |
| 17556942 | Dynamic Pressure Response System and Method for Measuring Residual Fluid | December 2021 | June 2024 | Allow | 30 | 4 | 0 | Yes | No |
| 17615924 | PRESSURE-MEASURING ASSEMBLY FOR AN EXTRACORPOREAL BLOOD TREATMENT MACHINE | December 2021 | May 2025 | Abandon | 41 | 2 | 0 | No | No |
| 17613400 | CONTROL SYSTEM | November 2021 | July 2025 | Abandon | 44 | 2 | 0 | No | No |
| 17613456 | SYSTEMS AND METHODS FOR EXTENDING OPERATIONAL TIME OF NEGATIVE PRESSURE WOUND TREATMENT APPARATUSES | November 2021 | January 2024 | Allow | 26 | 1 | 0 | Yes | No |
| 17609281 | BLOOD ANALYSIS SYSTEM | November 2021 | March 2025 | Allow | 40 | 1 | 0 | No | No |
| 17609218 | EMPTYING A BLOOD CIRCUIT AFTER EXTRACORPOREAL BLOOD TREATMENT | November 2021 | July 2025 | Allow | 44 | 2 | 0 | No | No |
| 17287046 | SYSTEM, COMPUTER SYSTEM AND COMPUTER PROGRAM FOR DETERMINING A CARDIOVASCULAR PARAMETER | November 2021 | November 2024 | Allow | 43 | 2 | 0 | Yes | No |
| 17606881 | MEDICAL FLUID TRANSFER APPARATUS | October 2021 | November 2024 | Allow | 37 | 2 | 0 | Yes | No |
| 17448811 | FLUID COLLECTION SYSTEMS INCLUDING AT LEAST ONE TENSIONING ELEMENT | September 2021 | June 2024 | Allow | 33 | 3 | 0 | Yes | No |
| 17480619 | ADJUSTABLE OUTER COVER FOR TWO PIECE ABSORBENT ARTICLE | September 2021 | June 2024 | Abandon | 32 | 2 | 1 | No | No |
| 17440008 | GARMENT INCLUDING A MICRO-PUMP FOR NON-FLUID MANAGEMENT TISSUE THERAPIES | September 2021 | May 2025 | Abandon | 44 | 4 | 1 | No | No |
| 17471488 | INTEGRATED PORTABLE APPARATUS FOR TOPICAL WOUND THERAPY, USING AMBIENT AIR FOR THE CREATION OF THREE BIOACTIVE GASES THAT INDEPENDENTLY AND SYNERGISTICALLY ASSIST IN THE RESOLUTION OF PATHOGENIC DERMATOLOGICAL CONDITIONS | September 2021 | September 2023 | Abandon | 24 | 1 | 0 | No | No |
| 17446246 | SYSTEMS AND METHODS INCLUDING A MALE FLUID COLLECTION DEVICE AND A SECUREMENT ELEMENT | August 2021 | August 2023 | Abandon | 24 | 0 | 1 | No | No |
| 17446251 | SYSTEMS AND METHODS INCLUDING A MALE FLUID COLLECTION DEVICE AND A SECUREMENT ELEMENT | August 2021 | August 2023 | Abandon | 24 | 0 | 1 | No | No |
| 17459845 | Compositions, Dispensers, and Methods Thereof for Establishing a Urine Passageway Through a Ureter | August 2021 | March 2025 | Allow | 42 | 2 | 1 | Yes | No |
| 17433769 | STERILE AZTREONAM PACKAGE | August 2021 | December 2024 | Allow | 39 | 3 | 1 | No | Yes |
| 17410132 | ABSORBENT ARTICLE WITH CONDUCTIVE MATERIAL ON TWO LAYERS | August 2021 | October 2023 | Abandon | 26 | 4 | 0 | No | No |
| 17409453 | DEVICE FOR IN-FLIGHT URINE ELIMINATION | August 2021 | September 2023 | Abandon | 25 | 1 | 1 | No | No |
| 17408396 | WEARABLE SYSTEM AND METHOD FOR MODIFICATION OF FLUID ENVIRONMENT OF AN EAR | August 2021 | July 2024 | Abandon | 35 | 1 | 1 | No | No |
| 17422325 | CONTROL ALGORITHM FOR NEGATIVE PRESSURE WOUND THERAPY DEVICES | July 2021 | July 2024 | Abandon | 36 | 2 | 0 | No | No |
| 17357580 | CHEM-O-PORT COVER | June 2021 | May 2024 | Abandon | 35 | 2 | 0 | No | No |
| 17341697 | ARTICLE HAVING A BOND PATTERN | June 2021 | January 2026 | Allow | 56 | 4 | 0 | No | Yes |
| 17339464 | PRESSURE CONTROL APPARATUS | June 2021 | December 2024 | Allow | 43 | 1 | 0 | No | No |
| 17309535 | Blood filtration systems | June 2021 | October 2024 | Allow | 40 | 1 | 0 | No | No |
| 17335525 | DISPOSABLE DIAPER | June 2021 | March 2025 | Allow | 45 | 2 | 0 | Yes | No |
| 17298358 | DEVICES FOR TOPICAL DELIVERY OF ACTIVE AGENTS TO A TARGET SITE | May 2021 | September 2024 | Abandon | 40 | 2 | 0 | No | No |
| 17325260 | ABSORBENT ARTICLES HAVING LAMINATES EXHIBITING VIBRANT GRAPHICS PERCEPTION | May 2021 | March 2026 | Abandon | 57 | 8 | 0 | No | No |
| 17295101 | TRANSDERMAL SYSTEM WITH OVERPLASTER AND RING SYSTEM | May 2021 | June 2025 | Abandon | 49 | 2 | 1 | No | No |
| 17292469 | INTRAUTERINE EXPANDER DEVICE | May 2021 | December 2023 | Abandon | 32 | 1 | 0 | No | No |
| 17315925 | FOOD ARRANGEMENT | May 2021 | April 2025 | Abandon | 47 | 2 | 0 | No | No |
| 17234765 | Undergarment for Colostomy Patients | April 2021 | April 2024 | Abandon | 35 | 2 | 0 | Yes | No |
| 17229114 | MULTI-FUNCTION IRRIGATION-ASPIRATION TUBING FOR OCULAR SURGERY DEVICES | April 2021 | February 2024 | Abandon | 34 | 2 | 0 | No | No |
| 17281999 | SCREEN EXCHANGE DEVICE, BIOLOGICAL TISSUE SIZE REDUCTION SYSTEM COMPRISING SAME, BIOLOGICAL TISSUE SIZE REDUCTION METHOD USING SAME, AND METHOD FOR SEPARATING TARGET SUBSTANCE FROM RELEVANT BIOLOGICAL TISSUE | April 2021 | November 2024 | Allow | 43 | 1 | 0 | No | No |
| 17280109 | OPTICAL FIBERS FOR OPTICALLY SENSING THROUGH WOUND DRESSINGS | March 2021 | November 2024 | Allow | 43 | 4 | 0 | Yes | No |
| 17277128 | WIRELESS SYSTEM TO ENABLE AUTO-DETERMINATION OF APPLICATION SPECIFIC THERAPY DEVICE SCREENS AND SETTING OPTIONS | March 2021 | April 2025 | Allow | 48 | 3 | 0 | No | No |
| 17202608 | THREE DIMENSIONAL NONWOVEN AND ABSORBENT ARTICLES HAVING THE SAME | March 2021 | January 2025 | Allow | 46 | 3 | 0 | No | No |
| 17275326 | ARTERIOVENOUS GRAFT SYSTEM, ARTERIOVENOUS VALVE DEVICE AND METHOD TO IMPLANT AN ARTERIOVENOUS GRAFT SYSTEM | March 2021 | May 2024 | Allow | 38 | 1 | 0 | No | No |
| 17175568 | EVERSIBLE CATHETER WITH MINIMAL RUBBING FRICTION | February 2021 | March 2023 | Allow | 25 | 1 | 0 | Yes | No |
| 17174457 | VARIABLE PARTICLE SIZE TISSUE COLLECTOR | February 2021 | August 2023 | Allow | 30 | 3 | 0 | Yes | No |
| 17173471 | ABSORBENT ARTICLE WITH FASTENING SYSTEM | February 2021 | September 2025 | Abandon | 56 | 6 | 0 | No | No |
| 17159462 | DURABLE ABSORBENT PANT | January 2021 | May 2025 | Allow | 52 | 5 | 0 | Yes | No |
| 17151598 | Urinary Catheter Suited for Hyperbaric Oxygen Therapy for Prostatitis | January 2021 | December 2023 | Abandon | 35 | 2 | 0 | No | No |
| 17151107 | CVC LINE BLOOD DRAWING METHOD | January 2021 | November 2024 | Abandon | 46 | 2 | 0 | No | No |
| 17258833 | FEMALE-FEMALE ADAPTER | January 2021 | January 2025 | Allow | 48 | 3 | 1 | Yes | No |
| 17138002 | CATHETERS WITH SHAPE LOCKING MECHANISMS | December 2020 | December 2023 | Allow | 35 | 4 | 0 | Yes | No |
| 17113333 | FLEXIBLE AND COMPLIANT MECHANICALLY-DEFORMED NONWOVENS FOR USE IN ABSORBENT ARTICLES | December 2020 | August 2025 | Abandon | 56 | 5 | 0 | No | No |
| 17093102 | Blood Treatment Systems | November 2020 | December 2024 | Allow | 49 | 5 | 0 | No | No |
| 17048354 | THIN FLUID ABSORBENT CORE-ABSORBENT PAPER | October 2020 | February 2025 | Allow | 52 | 4 | 0 | No | No |
| 17034850 | EPIDERMAL SUSPENSION SPRAY DEVICE | September 2020 | December 2024 | Abandon | 51 | 1 | 0 | No | No |
| 16978971 | Methods, Materials, Devices and Systems for Treating Injuries to Central Nervous System | September 2020 | September 2024 | Abandon | 48 | 2 | 0 | No | No |
| 16970788 | SYSTEMS AND METHODS FOR TRAUMA-FREE APPLICATION AND REMOVAL OF LIGHT DEACTIVATED ADHESIVE DRAPES | August 2020 | April 2024 | Allow | 44 | 1 | 0 | No | No |
| 16968435 | METHOD AND SYSTEM FOR MONITORING CARBON MONOXIDE (CO) ADMINISTRATION TO EX-VIVO FLUIDS | August 2020 | August 2024 | Abandon | 48 | 0 | 1 | No | No |
| 16983385 | SURGICAL SAFETY TOWEL | August 2020 | March 2024 | Abandon | 43 | 1 | 0 | No | No |
| 16944642 | Weight Loss Devices Having Anchor-Free Regions | July 2020 | June 2024 | Abandon | 47 | 1 | 0 | No | No |
| 16964780 | PEN NEEDLE COVER | July 2020 | April 2024 | Abandon | 45 | 1 | 0 | No | No |
| 16963567 | WETNESS INDICATING COMPOSITIONS INCLUDING AN AMPHIPHILIC POLYDIACETYLENE AND ABSORBENT ARTICLES INCLUDING THE SAME | July 2020 | November 2024 | Abandon | 52 | 2 | 0 | No | No |
| 16961440 | MODULAR EXTRACORPOREAL AMBULATORY LUNG ASSIST DEVICE | July 2020 | October 2024 | Allow | 51 | 3 | 0 | Yes | No |
| 16955636 | COMPOSITE WEBS | June 2020 | May 2024 | Abandon | 47 | 1 | 0 | No | No |
| 16636863 | ELASTIC MEMBER AND DISPOSABLE WEARING ARTICLE INCLUDING ELASTIC MEMBER | February 2020 | February 2026 | Allow | 60 | 6 | 0 | Yes | No |
| 16626039 | ABSORBENT ARTICLE AND METHOD FOR MANUFACTURING AN ABSORBENT ARTICLE | December 2019 | June 2024 | Allow | 53 | 2 | 0 | Yes | Yes |
| 16620764 | UNDERPANTS-TYPE DISPOSABLE DIAPER | December 2019 | August 2024 | Abandon | 56 | 2 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PHAM, KATHERINE-PH MINH.
With a 100.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner PHAM, KATHERINE-PH MINH works in Art Unit 3781 and has examined 64 patent applications in our dataset. With an allowance rate of 48.4%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 43 months.
Examiner PHAM, KATHERINE-PH MINH's allowance rate of 48.4% places them in the 11% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by PHAM, KATHERINE-PH MINH receive 2.36 office actions before reaching final disposition. This places the examiner in the 67% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by PHAM, KATHERINE-PH MINH is 43 months. This places the examiner in the 17% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +58.4% benefit to allowance rate for applications examined by PHAM, KATHERINE-PH MINH. This interview benefit is in the 96% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 25.4% of applications are subsequently allowed. This success rate is in the 40% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 20.0% of cases where such amendments are filed. This entry rate is in the 25% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
When applicants request a pre-appeal conference (PAC) with this examiner, 150.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 90% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 80.0% of appeals filed. This is in the 73% percentile among all examiners. Of these withdrawals, 75.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 133.3% are granted (fully or in part). This grant rate is in the 97% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 46% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.